You are here

  • Home
  • Archive
  • Volume 68, Issue 4
  • Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor

Article metrics

Article menu

This article has a correction. Please see:

Download PDFPDF
PostScript
Correspondence
Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor

 

Online download statistics by month:

Online download statistics by month: February 2015 to March 2024

AbstractFullPdf
Feb 20151391863
Mar 20151821216
Apr 2015941221
May 2015351113
Jun 20153488
Jul 2015421313
Aug 20152385
Sep 20153831
Oct 20151311
Nov 201527149
Dec 20157735
Jan 20163666
Feb 20162857
Mar 20161444
Apr 20161085
May 20162236
Jun 201635913
Jul 20163784
Aug 20162605
Sep 201628949
Oct 20166656
Nov 20167666
Dec 20162064
Jan 20172665
Feb 20173072
Mar 20174173
Apr 20172431
May 20171653
Jun 20174311
Jul 20174522
Aug 20174802
Sep 201710011
Oct 20175500
Nov 20177930
Dec 20174010
Jan 20186030
Feb 20184053
Mar 20183554
Apr 20189243
May 20183210
Jun 20185823
Jul 20184511
Aug 20183610
Sep 20183110
Oct 20182112
Nov 20182421
Dec 20183800
Jan 20196033
Feb 20191200
Mar 20194101
Apr 20194911
May 20192701
Jun 20195122
Jul 20192020
Aug 20193510
Sep 20192300
Oct 20192611
Nov 20195046
Dec 20194832
Jan 20203542
Feb 20202810
Mar 20202400
Apr 20203510
May 20202243
Jun 20203610
Jul 20201421
Aug 2020911
Sep 20202260
Oct 20202522
Nov 20203100
Dec 20203230
Jan 20217330
Feb 20213843
Mar 20214230
Apr 20214101
May 20212331
Jun 2021220
Jul 2021442
Aug 2021100
Sep 2021210
Oct 20212820
Nov 20216510
Dec 20213110
Jan 20222811
Feb 20223410
Mar 20224511
Apr 20225632
May 20227501
Jun 20225312
Jul 20224300
Aug 20229520
Sep 202211932
Oct 202212321
Nov 20223120
Dec 20226811
Jan 20235011
Feb 20238211
Mar 20234310
Apr 20231600
May 20233220
Jun 20231200
Jul 20233721
Aug 20233741
Sep 20232010
Oct 20235320
Nov 20234210
Dec 20234931
Jan 20241800
Feb 20243041
Mar 20243521
Total4592341358